Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Carmela, Zappalà"'
Autor:
Andrea Marino, Eleonora Caltabiano, Aldo Zagami, Anna Onorante, Carmela Zappalà, Maria Elena Locatelli, Alessio Pampaloni, Daniele Scuderi, Roberto Bruno, Bruno Cacopardo
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-5 (2018)
Abstract Background Highly active antiretroviral therapy has significantly changed the natural history of HIV infection, leading to a dramatic reduction of HIV-related morbidity and mortality. Late Presenters, Very Late Presenters and AIDS presenters
Externí odkaz:
https://doaj.org/article/5b7025d87ac248a0821b0e33ab45e823
Autor:
Patrizia, Marconi, Carmela, Zappalà, Alessia, Lofaro, Sara, Maiolino, Chiara, Mastellone, Maurizio, Belfiglio
Publikováno v:
Recenti progressi in medicina. 113(7)
Rare diseases have a high social and health impact. Since 2005, AIFA has been funding independent clinical research. The objective of this paper is to describe data on independent research on rare diseases financed by the Agency.With reference to stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ab7d3e058ad25cd83fb646813497e90
https://pubmed.ncbi.nlm.nih.gov/35852081
https://pubmed.ncbi.nlm.nih.gov/35852081
Autor:
Anna Onorante, Daniele Scuderi, Bruno Cacopardo, Aldo Zagami, Maria Elena Locatelli, Roberto Bruno, Eleonora Caltabiano, Carmela Zappalà, Alessio Pampaloni, Andrea Marino
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-5 (2018)
BMC Infectious Diseases
BMC Infectious Diseases
Background Highly active antiretroviral therapy has significantly changed the natural history of HIV infection, leading to a dramatic reduction of HIV-related morbidity and mortality. Late Presenters, Very Late Presenters and AIDS presenters still re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a063a16d2d55b8a690851225f505cbb4
http://hdl.handle.net/20.500.11769/359250
http://hdl.handle.net/20.500.11769/359250
Autor:
Marino, Andrea1 (AUTHOR) andreamarino9103@gmail.com, Caltabiano, Eleonora1 (AUTHOR) elecalt@tiscali.it, Zagami, Aldo1 (AUTHOR) aldozagami@alice.it, Onorante, Anna1 (AUTHOR) annaonorante@yahoo.it, Zappalà, Carmela1 (AUTHOR) melaniazappala@virgilio.it, Locatelli, Maria Elena1 (AUTHOR) mariaelena_locatelli@yahoo.it, Pampaloni, Alessio1 (AUTHOR) alepampa89@gmail.com, Scuderi, Daniele1 (AUTHOR) scuderi.dan@gmail.com, Bruno, Roberto1 (AUTHOR) bruno_roberto@virgilio.it, Cacopardo, Bruno1 (AUTHOR) cacopardobruno@inwind.it
Publikováno v:
BMC Infectious Diseases. 12/27/2018, Vol. 18 Issue 1, pN.PAG-N.PAG. 1p.
Autor:
Giovanni Lucignani
La sperimentazione clinica dei prodotti farmaceutici, e quindi anche dei radiofarmaci, è regolata a livello nazionale da decreti legislativi emessi per recepire specifiche Direttive europee in materia di buona pratica di sperimentazione, e da norme